Register for OBR daily




To find out more about a company click on the company name to see a brief profile.

OBR Finance Top 5 Winners

FATE $5.27 1.5700 +42.43%
ADXS $5.61 0.7500 +15.43%
ZIOP $4.80 0.5300 +12.41%
CVM $0.65 0.0657 +11.24%
ISIS $65.09 5.5400 +9.30%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

OBR Finance Top 5 Losers

IMGN $6.11 -4.7400 -43.69%
CBMG $12.55 -1.1400 -8.33%
GTXI $0.89 -0.0800 -8.25%
PARD $0.16 -0.0100 -5.88%
GLYC $8.64 -0.4200 -4.64%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

Archived News Headlines

We have been archiving all OBR daily news stories since March 2008. Use the box below to search our archives for specific articles and content.

Please note: we do not "host" news articles on our website. When a media source removes an article from their website the link becomes inactive, and you will only be able to see the date, title, first sentence and media source that published the article.

<< First | < Prev | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | Next > | Last >>

Dances with Pharma: Part 1 – Why Are Drugs So Expensive?

(Cancer Research UK/Science Blog) Dec 16, 2014 - In this first in a two-part series, we take a look at how cancer drugs get to patients, and at some of the reasons behind the spiralling costs.
read article 



Does Oncology Have a Recruitment Problem?

(Medscape Oncology) Dec 16, 2014 - With a potential shortage of oncologists looming, oncology fellows and physicians weigh in on recruitment issues facing the field.
read article (free registration required) 



Congress Fails to Act on Medicare Physician Payment Reform, SGR Repeal

(ASCO in Action) Dec 16, 2014 - The 113th Congress failed to pass the “SGR Repeal and Medicare Provider Payment Modernization Act of 2014 (S 2000/HR 4015),” the bipartisan, bicameral measure introduced earlier in the year that would have repealed the fundamentally flawed sustainable growth rate (SGR) formula and replaced it with a more stable, fair payment system.
read article 



Myriad Loses Appeals Court Bid to Block Breast Cancer Tests

(Bloomberg) Dec 17, 2014 - Myriad Genetics Inc. lost its bid to block competing DNA tests to determine risk for breast and ovarian cancer after a U.S. appeals court said three patents on the tests never should have been issued.
read article 



Vessel Research Offers New Direction to Study How Cancer Spreads

(Cornell University) Dec 16, 2014 - Researchers have understood very little about how blood and lymphatic vessels form in the mammalian gut – until now.
read article 



Long Noncoding RNAs: A Novel Prognostic Marker in Older Patients with Acute Leukemia

(OSUCCC - James) Dec 14, 2014 - A new study describes a novel marker that might help doctors choose the least toxic, most effective treatment for many older patients with acute myeloid leukemia (AML).
read press release 



Single Genetic Abnormality Accelerates, Removes the Brakes on Ewing Sarcoma Tumor Growth

(Mass General) Dec 16, 2014 - Changes in gene regulation could be targets for treatment strategies.
read press release 



Combining Images and Genetic Data Proves Gene Loss Behind Aggressive Ovarian Cancers

(Cancer Research UK) Dec 17, 2014 - Cancer Research UK scientists have shown that loss of a gene called PTEN triggers some cases of an aggressive form of ovarian cancer, called high-grade serous ovarian cancer, according to a study published in Genome Biology.
read press release 



No Chemo: Agent Represents a 'New Way of Thinking About AML'

(Medscape Medical News) Dec 16, 2014 - The response rates and tolerability of a first-in-class oral agent are being called excellent, and there is talk of transforming the care of acute myeloid leukemia (AML).
read article (free registration required) 



Cancer Screening May Benefit Diabetes Patients

(dailyRx News) Dec 16, 2014 - Type 1 and type 2 diabetes patients had higher risk for cancers of the pancreas, liver and esophagus, among others.
read article 



Insomnia in Cancer Patients: CBI Is a Mainstay

(Medscape Medical News) Dec 16, 2014 - A study in cancer survivors found that adding a wakefulness-promoting drug did not improve on cognitive behavior therapy for insomnia (CBT-I) alone.
read article (free registration required) 



3D Printing Points Way to Smarter Cancer Treatment

(Reuters) Dec 16, 2014 - British scientists have developed a new use for 3D printing, putting it to work to create personalized replica models of cancerous parts of the body to allow doctors to target tumors more precisely.
read article 



How Calling Cancer a ‘Fight’ or ‘Battle’ Can Harm Patients

(Time) Dec 17, 2014 - Using hostile, warlike metaphors to describe cancer may make patients less likely to take steps toward certain treatments, new research suggests.
read article 



FDA Approves Lanreotide For Gastroenteropancreatic Tumors

(ASCO in Action) Dec 16, 2014 - On December 16, 2014, the U. S. Food and Drug Administration approved lanreotide (Somatuline® Depot Injection, Ipsen Pharma) for the treatment of patients with unresectable, well or moderately differentiated, locally advanced or metastatic gastroenteropancreatic neuroendocrine tumors (GEP-NETs) to improve progression-free survival.
read article 



Exclusive: Amgen's New Leukemia Drug to Carry $178,000 Price Tag

(Reuters) Dec 17, 2014 - Amgen Inc on Wednesday said its new type of treatment for a deadly form of leukemia would cost about $178,000 when it becomes available on Thursday, which would make it one of the world's most expensive cancer drugs.
read article 



Ipsen Announces the FDA Approval of Somatuline Depot (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors

(TheStreet) Dec 16, 2014 - Ipsen Biopharmaceuticals, Inc., an affiliate of Ipsen, today announced that Somatuline® Depot® (lanreotide) Injection 120 mg (referred to as Somatuline®) was approved by the U.S. Food and Drug Administration (FDA) for the treatment of gastroenteropancreatic neuroendocrine tumors (GEP-NETs) in adult patients with unresectable, well or moderately differentiated, locally advanced or metastatic disease to improve progression-free survival (PFS).
read article 



Solutions Needed to Stem Cancer Costs, ASH Experts Say

(Medscape Medical News) Dec 16, 2014 - In a special session at ASH, an expert panel discussed rising cancer costs, especially for new drugs, and the solutions needed to stem the tide while still offering quality care to patients.
read article (free registration required) 



Novartis Gets U.S. Approval for Hormonal Disorder Drug

(NASDAQ/Dow Jones Business News) Dec 16, 2014 - Novartis AG said Tuesday its Signifor injectable drug has received U.S. regulatory approval for treating patients with a life-threatening hormonal disorder.
read article 



The Morning Risk Report: New Drug Supply Chain Rules Set to Take Effect

(Wall Street Journal/Risk & Compliance blog) Dec 16, 2014 - Drug manufacturers will have to adhere to new rules governing the chain of custody for pharmaceuticals as they move through the supply chain, with others in the distribution system eventually having to come into compliance. The Drug Quality and Security Act takes effect Jan. 1, 2015.
read article (paid subscription required) 



Senate, Ending Long Battle, Confirms Nominee for Surgeon General

(New York Times) Dec 15, 2014 - The confirmation of Dr. Vivek H. Murthy, questioned for his gun-control views, was one of the last acts of business for the Democratic-controlled Senate.
read article 



FDA Approves Blood Test That Gauges Heart Attack Risk

(Doctors Lounge/HealthDay News) Dec 15, 2014 - The U.S. Food and Drug Administration on Monday approved a new blood test that can help determine a person's future odds for heart attack and other heart troubles.
read article 



Do Patients Mind If Their Healthcare Data Is Shared? It Depends

(Reuters Health) Dec 15, 2014 - Healthcare data may be valuable to researchers and companies, but patients' comfort levels about having their data shared may depend on the purpose, a new survey suggests.
read article 



Infusionarium Aims to Take Trauma Out of Chemotherapy for Young

(New York Times/Well blog) Dec 15, 2014 - Cancer treatments can be particularly hard on children. But in the Infusionarium their minds are transported to mountain slopes where they are surrounded by extreme skiers or Disney princesses.
read article 



USF Health, Moffitt Cancer Center Launch Region’s First Academic Cardio-Oncology Program

(Moffitt Cancer Center) Dec 15, 2014 - Approximately 30 percent of all cancer patients develop cardiovascular complications during treatment. USF Health and Moffitt Cancer Center are taking aim to reduce this risk by launching Florida’s first comprehensive academic Cardio-Oncology Program.
read press release 



USP 800 Revision Released

(ASCO in Action) Dec 15, 2014 - The United States Pharmacopeial Convention (USP) recently released a revised version of the proposed General Chapter 800, “Hazardous Drugs – Handling in Healthcare Settings,” due to the nature and significance of the comments received on the original proposal.
read article